Head to head
FlexSure vs Venus Versa (2026)
Compare purchase costs, running costs and the evidence behind each device.
Read the comparison overview
- Purchase cost
- Catalog new-price ranges: FlexSure, $40k–$70k; Venus Versa, $70k–$110k. Check the source notes and request current quotes.
- Practice fit
- Both are listed under body contouring. Check each model’s US regulatory status and labeled indications for your intended use.
Body Contouring
View full device profile →Body Contouring
View full device profile →Price comparison
New price range
- Cynosure FlexSure
- $40k–$70kSource not documented
- Venus Versa
- $70k–$110kSource not documented
Used asking range
- Cynosure FlexSure
- Not published
- Venus Versa
- $20k–$45kSource not documented
Payback calculator
- Cynosure FlexSure
- View ROI calculator
- Venus Versa
- View ROI calculator
Next step
Consumable economics
Consumable cost / lock-in
- Cynosure FlexSure
- —
- Venus Versa
- Supply pricing is not documented with a dated source yet. Request an itemized supply quote. — soft-lock (defeatable) — internal shot-count chip, resettable by third-party refurbishers
Service cost
- Cynosure FlexSure
- Not published
- Venus Versa
- Not published
FDA clearance
FDA status & indication
- Cynosure FlexSure
- FDA ClearedK200241
Read FDA indication wording
“The TempSure™ System has the following indications for use: The 10mm, 15mm, and 20mm Smart Handpieces are indicated for non-ablative treatment of mild to moderate facial wrinkles and rhytids. The 18mm, 25mm, 30mm, 60mm Smart Handpieces and FlexSure™ applicators provide heating for the purpose of elevating tissue temperature for selected medical conditions such as temporary relief of pain, muscle spasms, and increase in local circulation. The massage device is intended to provide a temporary reduction in the appearance of cellulite. The following surgical modes are applicable to the generator: Coagulation/Hemostasis: General surgical procedures including urologic, thoracic, plastic, reconstructive, and gynecological procedures where electrosurgical coagulation of tissue is performed. Cutting: snoring, submucosal palatal shrinkage, traditional uvulopalatoplasty (RAUP), myringotomy with effective hemorrhage control, epistaxis treatment, turbinate shrinkage, skin incisions, biopsy, cysts, abscesses, tumors, cosmetic repairs, development of skin flaps, skin tags and blepharoplasty. Blended Cutting and Coagulation: snoring, submucosal palatal shrinkage, traditional uvulopalatoplasty (RAUP), myringotomy with effective hemorrhage control, epistaxis treatment, turbinate shrinkage, skin tags, papilloma keloids, keratosis, verrucae, basal cell carcinoma, nevi, fistulas, epithelioma, cosmetic repairs, cysts, abscesses, and development of skin flaps. Fulguration: basal cell carcinoma, papilloma, cyst destruction, tumors, verrucae, hemostasis. Bipolar: pinpoint precise coagulation, pinpoint hemostasis in any field (wet or dry), snoring, submucosal palatal shrinkage, traditional uvulopalatoplasty (RAUP), myringotomy with effective hemorrhage control, epistaxis treatment and turbinate shrinkage.”
- Venus Versa
- FDA ClearedK153717
Read FDA indication wording
“The Venus Versa System is a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 IPL applicators are indicated for the following: • Treatment of benign pigmented epidermal and cutaneous lesions including: hyperpigmentation, melasma, ephelides (freckles), lentigines, nevi, and cafe-au-lait macules. • Treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, angiomas and spider angiomas, poikiloderma of civatte, leg veins and venous malformations. The HR650, HR690, HR650XL, and HR690XL IPL applicators are indicated for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for skin types I-IV. Permanent hair reduction is defined as the longterm stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen. The Venus Concept ACDUAL applicator is intended to be used for the treatment of acne vulgaris. The Diamondpolar and Octipolar applicators are non-invasive devices intended for use in dermatologic and general surgery procedures for females for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV. The Viva applicator is intended for dermatological procedures requiring ablation and resurfacing of the skin.”
Which chains run each
Chain adoption
- Cynosure FlexSure
- 0 recorded pairings
- Venus Versa
- 1 recorded pairing
Chains using it
- Cynosure FlexSure
- —
- Venus Versa
- Formula Wellness(Confirmed)
Approved reviews
- Cynosure FlexSure
- 0
- Venus Versa
- 0
Specs and platform
Manufacturer
- Cynosure FlexSure
- Cynosure
- Venus Versa
- Venus Concept
Built by (OEM)
- Cynosure FlexSure
- Cynosure LLC
- Venus Versa
- Venus Concept Inc.
Category
- Cynosure FlexSure
- Body Contouring
- Venus Versa
- Body Contouring
Technology
- Cynosure FlexSure
- Wrap-around hands-free RF applicators
- Venus Versa
- Multi-application platform w/ body RF (IPL)
Launch year
- Cynosure FlexSure
- 2021
- Venus Versa
- 2016
Status
- Cynosure FlexSure
- Current
- Venus Versa
- Current
Manufacturer source record
- Cynosure FlexSure
- No linked source on file.
- Venus Versa
- No linked source on file.
Current alternatives
Current catalog models in related categories. Confirm availability and configuration with the supplier.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.